Approval · Notice of Compliance 34754 · 2025
DOPTELET: Notice of Compliance 34754
Issued January 27, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34754
- Date
- January 27, 2025
- Company
- Swedish Orphan Biovitrum Ab (Publ)Stockholm, --, Sweden
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOPTELET | Not yet assigned | — |
Medicinal ingredients
- AVATROMBOPAG MALEATE 20 MG per TAB